Long–Term Incentive Compensation (Details Narrative) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||
| Common Stock, Capital Shares Reserved for Future Issuance | 15,000,000 | 15,000,000 | ||
| Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant | 13,215,489 | 13,215,489 | ||
| Stock based compensation costs | $ 3,722 | $ 3,451 | ||
| Equity Classified Awards [Member] | ||||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||
| Stock based compensation costs | $ 1,200 | 2,100 | 3,300 | |
| Equity Classified Restricted Stock Units [Member] | ||||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||
| Cost not yet recognized | $ 3,300 | $ 3,300 | ||
| Remaining term | 1 year 7 months 17 days | |||
| Equity Classified Performance Stock Units [Member] | ||||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||
| Stock based compensation costs | 1,100 | $ 100 | $ 1,600 | $ 100 |
| Cost not yet recognized | $ 3,500 | $ 3,500 | ||
| Remaining term | 1 year 6 months | |||
| Liability Classified Restricted Stock Units [Member] | ||||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||
| Share based compensation, description | The Company has also granted RSUs to certain of its directors and advisors, which primarily vest one year following the grant date, subject to the director’s or advisor’s continued service through the applicable vesting date. Such RSUs are payable 60% in Common Stock and 40% in either cash or Common Stock (or a combination thereof), as determined by the Committee. The Company has accounted for the portion of the awards that can be settled in cash as liability–classified awards and accordingly records the changes in the market value of the instruments to general and administrative expense over the vesting period of the award. | |||